openPR Logo
Press release

Chimeric Antigen Receptor T (CAR-T) Cells Market Size 2023, New Trends, Future Prospects, Industry Analysis, Top Players, Opportunities And Forecast To 2032 - Novartis International AG, Pfizer Inc., Gilead Sciences Inc

Chimeric Antigen Receptor T (CAR-T) Cells Market

Chimeric Antigen Receptor T (CAR-T) Cells Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Chimeric Antigen Receptor T (CAR-T) Cells Market Size, Growth Rate, And Forecast

The global chimeric antigen receptor T (CAR-T) cells market size is expected to grow from $1.96 billion in 2022 to $2.76 billion in 2023 at a compound annual growth rate (CAGR) of 40.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chimeric antigen receptor T (CAR-T) cells market size is expected to grow to $10.24 billion in 2027 at a CAGR of 38.8%.

Request A Free Sample Of The Chimeric Antigen Receptor T (CAR-T) Cells Market Report Here ---
https://www.thebusinessresearchcompany.com/sample.aspx?id=8124&type=smp

Chimeric Antigen Receptor T (CAR-T) Cells Market Drivers

The increasing occurrences of cancer is driving the chimeric antigen receptor T (CAR-T) cells market. Cancer is a chronic disease in which normal body cells divide and grow without any control and affect the nearest body tissue and turn into tumor cells. The chimeric antigen receptor T (CAR-T) cells are used to treat various types of cancers such as haematological malignancies, including acute lymphoblastic leukemia and chronic lymphocytic leukemia, and can also treat solid tumors such as breast cancer and sarcoma.

Learn More On The Chimeric Antigen Receptor T (CAR-T) Cells Market Report Here:
https://www.thebusinessresearchcompany.com/report/chimeric-antigen-receptor-t-car-t-cells-global-market-report

Chimeric Antigen Receptor T (CAR-T) Cells Market Segments
• By Target Antigen: CD19, CD22, Other Antigens

• By Application: Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Other Applications

• By End User: Hospitals, Cancer Research Centres, Clinics

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Chimeric Antigen Receptor T (CAR-T) Cells market.

Check Out Buying Options For The Chimeric Antigen Receptor T (CAR-T) Cells Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8124

Chimeric Antigen Receptor T (CAR-T) Cells Market Key Players

Major competitors in the chimeric antigen receptor T (CAR-T) cells market are Novartis International AG, Pfizer Inc., Gilead Sciences Inc., Autolus Therapeutics Plc, CARsgen Therapeutics Company Limited, Bristol-Myers Squibb Company.

The Business Research Company's "Global Chimeric Antigen Receptor T (CAR-T) Cells Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table Of Content For The Chimeric Antigen Receptor T (CAR-T) Cells Market Include:
1. Executive Summary
2. Chimeric Antigen Receptor T (CAR-T) Cells Market Characteristics
3. Chimeric Antigen Receptor T (CAR-T) Cells Market Trends And Strategies
4. Chimeric Antigen Receptor T (CAR-T) Cells Market - Macro Economic Scenario
5. Chimeric Antigen Receptor T (CAR-T) Cells Market Size And Growth
………………
27. Chimeric Antigen Receptor T (CAR-T) Cells Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Chimeric Antigen Receptor T (CAR-T) Cells Market
29. Chimeric Antigen Receptor T (CAR-T) Cells Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, seafood, seafood, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chimeric Antigen Receptor T (CAR-T) Cells Market Size 2023, New Trends, Future Prospects, Industry Analysis, Top Players, Opportunities And Forecast To 2032 - Novartis International AG, Pfizer Inc., Gilead Sciences Inc here

News-ID: 3007401 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Antigen

Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: Cr …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market encompassing carcinoembryonic antigen has experienced swift expansion lately, projected to progress from a valuation of $1.22 billion in 2024 to $1.38 billion the following year, reflecting a robust compound annual growth rate of
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth: A …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Carcinoembryonic Antigen Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The size of the carcinoembryonic antigen market has experienced swift growth in the previous years. There will be an increase from $1.22 billion in 2024 to $1.38 billion in 2025, exhibiting a compound annual growth
Increasing Incidence Of Cancer Drives Carcinoembryonic Antigen Market Growth Dri …
What combination of drivers is leading to accelerated growth in the carcinoembryonic antigen market? The surge in cancer cases is anticipated to fuel the expansion of the carcinoembryonic antigen market in the future. Cancer is an ailment identified by unregulated proliferation and dissemination of irregular cells. The prevalence of cancer is increasing owing to aspects such as lifestyle alternatives, environmental contamination, genetic susceptibility, and a growing elderly population. Carcinoembryonic antigen (CEA)
COVID-19 Antigen Test Market Report 2024 - COVID-19 Antigen Test Market Growth A …
"The Business Research Company recently released a comprehensive report on the Global COVID-19 Antigen Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, the covid-19 antigen
COVID-19 Antigen Test Market Report 2024 - COVID-19 Antigen Test Market Size And …
"The Business Research Company recently released a comprehensive report on the Global COVID-19 Antigen Test Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The covid-19 antigen
CEACAM8 Antigen Gene Market Unveiling the Enigma: The CEACAM8 Antigen Gene Marke …
CEACAM8 Antigen Gene Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global CEACAM8 Antigen Gene Market Size, Share & Trends Analysis Report By Type (Above 95%, Above 99%, Others), By Application (Biopharmaceutical Companies, Hospitals, Bioscience Research Institutions, Others)- Market Outlook And Industry Analysis 2031" The Global CEACAM8 Antigen Gene Market is estimated